← Back to Patent Explorer
US3696116A Expired / Lapsed US ⏱️ 0.0 years remaining

1-(2-aminocarbonyloxyethyl)-5-nitro-imidazole derivatives having antiprotozoal activity

Assignee: Rhone Poulenc SA
•
Filing: 1970-07-15
•
Granted: 1972-10-03
•
Expires: 1990-07-15
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Imidazole derivatives of the formula: WHEREIN R represents hydrogen or alkyl of one through four carbon atoms, R1 represents hydrogen, alkyl of one through five carbon atoms, or hydroxy, and R2 represents hydrogen or alkyl of one through five carbon atoms, possess anti-protozoal activity, especially against the pathogenic protozoa of amoebiasis and trichomoniasis.

Inventors

  • 👤 Claude Jeanmart
  • 👤 Mayer Naoum Messer

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 12:48
CPC Classifications
C; C07; C07D; C07D233/00; C07D233/54; C07D233/66; C07D233/91; C07D233/92; C07D233/94

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 17 words
An imidazole derivative according to claim 1 wherein R represents alkyl of one through four carbon atoms.
Claim 2
Dependent Claim 11 words
An imidazole derivative according to claim 1 wherein R represents methyl.
Claim 3
Dependent Claim 19 words
The imidazole derivative according to claim 1 which is 1-(2-aminocarbonyloxyethyl)-2-methyl-5-nitromidazole or a pharmaceutically acceptable non-toxic acid addition salt thereof.
Claim 4
Dependent Claim 19 words
The imidazole derivative according to claim 1 which is 1-(2-methylaminocarbonyloxyethyl)-2-methyl-5-nitroimidazole or a pharmaceutically acceptable non-toxic acid addition salt thereof.
Claim 5
Dependent Claim 19 words
The imidazole derivative according to claim 1 which is 1-(2-hydroxyaminocarbonyloxyethyl)-2-methyl-5-nitroimidazole or a pharmaceutically acceptable non-toxic acid addition salt thereof.
Claim 6
Dependent Claim 19 words
The imidazole derivative according to claim 1 which is 1-(2-dimethylaminocarbonyloxyethyl)-2-methyl-5-nitromidazole or a pharmaceutically acceptable non-toxic acid addition salt thereof.

References Cited (Backward Citations)

GB1153346A Cited
US3505349A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1975-10-03 1976-04-03 1976-10-03 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1979-10-03 1980-04-03 1980-10-03 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1983-10-03 1984-04-03 1984-10-03 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag